Home
GDTC
GDTC News

Latest CytoMed Therapeutics Limited (GDTC) News on September 4, 2025

MT Newswires

3 months ago

CytoMed Therapeutics Files $50 Million Mixed Shelf

CytoMed Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

4 months ago

CytoMed Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

GlobeNewswire

4 months ago

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders

GlobeNewswire

7 months ago

CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders

Anebulo Pharmaceuticals Leads This Trio Of US Penny Stocks

Simply Wall St.

7 months ago

Anebulo Pharmaceuticals Leads This Trio Of US Penny Stocks

CytoMed and SunAct Collaborate on Cancer Immunotherapy Trials in India

TipRanks

8 months ago

CytoMed and SunAct Collaborate on Cancer Immunotherapy Trials in India

MT Newswires

8 months ago

Top Premarket Decliners

CytoMed Therapeutics and SunAct to conduct solid tumour treatment trial in India

Clinical Trials Arena

8 months ago

CytoMed Therapeutics and SunAct to conduct solid tumour treatment trial in India

MT Newswires

8 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires

8 months ago

CytoMed, SunAct Cancer Institute Sign 5-Year Collaboration Deal for Phase 2 Clinical Trial in India

CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial in India

GlobeNewswire

8 months ago

CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial in India

CytoMed Therapeutics Leads 3 US Penny Stocks To Consider

Simply Wall St.

8 months ago

CytoMed Therapeutics Leads 3 US Penny Stocks To Consider

CytoMed Therapeutics And 2 Other US Penny Stocks To Watch

Simply Wall St.

9 months ago

CytoMed Therapeutics And 2 Other US Penny Stocks To Watch

Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies

GlobeNewswire

9 months ago

Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies

Discovering Penny Stocks On US Exchanges: 3 Picks Under $100M Market Cap

Simply Wall St.

10 months ago

Discovering Penny Stocks On US Exchanges: 3 Picks Under $100M Market Cap

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

GlobeNewswire

a year ago

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

CytoMed Acquires Cord Blood Assets, Eyes Regenerative Medicine

TipRanks

a year ago

CytoMed Acquires Cord Blood Assets, Eyes Regenerative Medicine

CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank

GlobeNewswire

a year ago

CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank

CytoMed Therapeutics Reports Six Months Ended June 30, 2024 Financial Results and Provides Clinical and Corporate Updates

GlobeNewswire

a year ago

CytoMed Therapeutics Reports Six Months Ended June 30, 2024 Financial Results and Provides Clinical and Corporate Updates

Presenting on the Emerging Growth Conference 75 Day 2 on September 26

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 75 Day 2 on September 26

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

GlobeNewswire

a year ago

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

ACCESSWIRE

a year ago

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

GlobeNewswire

a year ago

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

GlobeNewswire

2 years ago

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference

ACCESSWIRE

2 years ago

Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

GlobeNewswire

2 years ago

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

First Community (NASDAQ:FCCO) Will Pay A Dividend Of $0.14

Simply Wall St.

2 years ago

First Community (NASDAQ:FCCO) Will Pay A Dividend Of $0.14

Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock

GlobeNewswire

2 years ago

Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock

Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split

ACCESSWIRE

2 years ago

Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split

Timberland Bancorp Inc (TSBK) Reports First Fiscal Quarter Results

GuruFocus.com

2 years ago

Timberland Bancorp Inc (TSBK) Reports First Fiscal Quarter Results

Jasper Therapeutics (JSPR) Surges 110% in a Month: Here's Why

Zacks

2 years ago

Jasper Therapeutics (JSPR) Surges 110% in a Month: Here's Why

The Joint Chiropractic Named No. 1 in Chiropractic Services, Ranked Among Top Franchises in Entrepreneur Magazine's Franchise 500

PR Newswire

2 years ago

The Joint Chiropractic Named No. 1 in Chiropractic Services, Ranked Among Top Franchises in Entrepreneur Magazine's Franchise 500

SmarFinancial (SMBK) Q4 Earnings and Revenues Miss Estimates

Zacks

2 years ago

SmarFinancial (SMBK) Q4 Earnings and Revenues Miss Estimates

Is Ingredion (INGR) Stock Outpacing Its Consumer Staples Peers This Year?

Zacks

2 years ago

Is Ingredion (INGR) Stock Outpacing Its Consumer Staples Peers This Year?

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

ACCESSWIRE

2 years ago

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

We're Keeping An Eye On International Tower Hill Mines' (TSE:ITH) Cash Burn Rate

Simply Wall St.

2 years ago

We're Keeping An Eye On International Tower Hill Mines' (TSE:ITH) Cash Burn Rate

Why the Market Dipped But inTest Corporation (INTT) Gained Today

Zacks

2 years ago

Why the Market Dipped But inTest Corporation (INTT) Gained Today

Forum Energy Technologies to Present at the Sidoti Virtual Investor Conference

Business Wire

2 years ago

Forum Energy Technologies to Present at the Sidoti Virtual Investor Conference

Richardson Electronics (NASDAQ:RELL) Is Paying Out A Dividend Of $0.06

Simply Wall St.

2 years ago

Richardson Electronics (NASDAQ:RELL) Is Paying Out A Dividend Of $0.06

ASP Isotopes Inc. Provides Corporate Update

GlobeNewswire

2 years ago

ASP Isotopes Inc. Provides Corporate Update

Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024

ACCESSWIRE

2 years ago

Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024

BioCryst (BCRX) Moves 25.6% Higher: Will This Strength Last?

Zacks

2 years ago

BioCryst (BCRX) Moves 25.6% Higher: Will This Strength Last?

Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer

GlobeNewswire

2 years ago

Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer

Solid Biosciences Announces $109 Million Private Placement

GlobeNewswire

2 years ago

Solid Biosciences Announces $109 Million Private Placement

Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece

ACCESSWIRE

2 years ago

Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece

The Zacks Analyst Blog Highlights Murphy USA, Nine Energy Service and Sunoco

Zacks

2 years ago

The Zacks Analyst Blog Highlights Murphy USA, Nine Energy Service and Sunoco

Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH™

GlobeNewswire

2 years ago

Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH™

Riverview Bancorp (NASDAQ:RVSB) Has Announced A Dividend Of $0.06

Simply Wall St.

2 years ago

Riverview Bancorp (NASDAQ:RVSB) Has Announced A Dividend Of $0.06

D-Market Elektronik Hizmetler ve Ticaret (NASDAQ:HEPS) Is Looking To Continue Growing Its Returns On Capital

Simply Wall St.

2 years ago

D-Market Elektronik Hizmetler ve Ticaret (NASDAQ:HEPS) Is Looking To Continue Growing Its Returns On Capital

One CytoMed Therapeutics Insider Raised Stake By 46% In Previous Year

Simply Wall St.

2 years ago

One CytoMed Therapeutics Insider Raised Stake By 46% In Previous Year

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

Business Wire

2 years ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

Business Wire

2 years ago

Park City Group, Inc. d/b/a ReposiTrak Formalizes Corporate Name Change to ReposiTrak, Inc.

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease

ACCESSWIRE

2 years ago

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease

Ondas Holdings Inc. (NASDAQ:ONDS) Shares Could Be 32% Above Their Intrinsic Value Estimate

Simply Wall St.

2 years ago

Ondas Holdings Inc. (NASDAQ:ONDS) Shares Could Be 32% Above Their Intrinsic Value Estimate

Recent Price Trend in TScan Therapeutics, Inc. (TCRX) is Your Friend, Here's Why

Zacks

2 years ago

Recent Price Trend in TScan Therapeutics, Inc. (TCRX) is Your Friend, Here's Why

Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners

ACCESSWIRE

2 years ago

Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners

Mama’s Creations to Host Third Quarter Fiscal 2024 Earnings Call on December 12 at 4:30 p.m. Eastern Time

GlobeNewswire

2 years ago

Mama’s Creations to Host Third Quarter Fiscal 2024 Earnings Call on December 12 at 4:30 p.m. Eastern Time

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

PR Newswire

2 years ago

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Cheetah Mobile Announces Acquisition of Controlling Stake in Beijing OrionStar

PR Newswire

2 years ago

Cheetah Mobile Announces Acquisition of Controlling Stake in Beijing OrionStar

Glatfelter (NYSE:GLT) investors are sitting on a loss of 90% if they invested three years ago

Simply Wall St.

2 years ago

Glatfelter (NYSE:GLT) investors are sitting on a loss of 90% if they invested three years ago

PGIM Closed-End Funds declare distributions for December 2023, January and February 2024

Business Wire

2 years ago

PGIM Closed-End Funds declare distributions for December 2023, January and February 2024

Citi Trends (CTRN) Q3 2023 Earnings Call Transcript

Motley Fool

2 years ago

Citi Trends (CTRN) Q3 2023 Earnings Call Transcript

Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference

ACCESSWIRE

2 years ago

Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference

InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions

GlobeNewswire

2 years ago

InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions

7 Penny Stocks With Low Floats and High Short Interest

InvestorPlace

2 years ago

7 Penny Stocks With Low Floats and High Short Interest

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference

PR Newswire

2 years ago

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference

Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting

Business Wire

2 years ago

Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting

Smart Share Global Limited to Report Third Quarter 2023 Results on November 27, 2023

GlobeNewswire

2 years ago

Smart Share Global Limited to Report Third Quarter 2023 Results on November 27, 2023

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

PR Newswire

2 years ago

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

PR Newswire

2 years ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Ascent Industries Co. (NASDAQ:ACNT) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Ascent Industries Co. (NASDAQ:ACNT) Q3 2023 Earnings Call Transcript

Wag! Group Co.'s (NASDAQ:PET) Shares Not Telling The Full Story

Simply Wall St.

2 years ago

Wag! Group Co.'s (NASDAQ:PET) Shares Not Telling The Full Story

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q3 2023 Earnings Call Transcript

Weak Financial Prospects Seem To Be Dragging Down Vox Royalty Corp. (TSE:VOXR) Stock

Simply Wall St.

2 years ago

Weak Financial Prospects Seem To Be Dragging Down Vox Royalty Corp. (TSE:VOXR) Stock

Destra Multi-Alternative Fund Announces Changes to Portfolio Holdings Disclosure Practices

Business Wire

2 years ago

Destra Multi-Alternative Fund Announces Changes to Portfolio Holdings Disclosure Practices

Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

GlobeNewswire

2 years ago

Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

Business Wire

2 years ago

LL Flooring Reports Third Quarter 2023 Financial Results

Fortune Rise Acquisition Corporation Receives November Monthly Extension From Sponsor Affiliate to Complete its Initial Business Combination

ACCESSWIRE

2 years ago

Fortune Rise Acquisition Corporation Receives November Monthly Extension From Sponsor Affiliate to Complete its Initial Business Combination

Share on Social Networks: